Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 357

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 357
---
 Purchaser to the Representative under this
Agreement; that the Representative may disclose any such update or other information to the Representative.

During the
Disposition Period (including any Tail Period), upon the reasonable written request from the Representative, Purchaser will provide: (i) the Representative with a written update in reasonable detail describing the progress, status and
anticipated trajectory of efforts in respect of the Disposition Agreement; and (ii) the anticipated timing of receiving payments in respect of the Disposition Agreements, in each case up to (A) one time in a fiscal quarter of each calendar
year during the Disposition Period and (B) one time during the Tail Period. The Representative agrees to maintain the confidentiality of any such update or other confidential information provided by Purchaser to the Representative under this
Agreement; that the Representative may disclose any such update or other information to the Representative of its Affiliates.

In the event that Purchaser desires to consummate a Change of Control or other disposition of the CVR Products prior to the Expiration Date,
Purchaser shall cause the Person acquiring the assets, shares or voting

A-100

interests in the Company (or its successor) or the applicable CVR Products, as applicable, to assume Purchaser’s or its successor’s (as applicable depending upon the structure of the
Change of Control) obligations, duties and covenants under this Agreement. No later than five (5) Business Days after the consummation of any Change of Control or other transaction, Purchaser will deliver to the Rights Agent an Officer’s
Certificate, stating that such Change of Control or other transaction complies with this Section 4.6(i) and that all conditions precedent herein relating to such transaction have been complied with.

AMENDMENTS

Without the consent of any Holders, the Representative, Purchaser and the Rights Agent, at any
time and from time to time, may enter into one or more amendments hereto, for any of the following purposes:

to evidence the succession
of another Person to Purchaser and the assumption by any such successor of the covenants of Purchaser herein as provided in ; that, in each case, such provisions do not adversely affect the interests of the
Holders;

to add to the covenants of Purchaser such further covenants, restrictions, conditions or provisions as the Representative,
Purchaser and the Rights Agent will consider to be for the protection of the Holders;

to cure any ambiguity, to correct or supplement